ZyVersa Therapeutics, Inc. (ZVSA)

NASDAQ: ZVSA · IEX Real-Time Price · USD

5.29

-0.48 (-8.32%)

At close: Apr 30, 2024, 4:00 PM

5.24

-0.05 (-0.95%)

Pre-market: May 1, 2024, 5:41 AM EDT

ZyVersa Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	4	4	246	97	-
Market Cap Growth	-	-98.24%	153.38%	-	-
Enterprise Value	1	1	246	106	4
PE Ratio	-0.04	-0.04	-10.23	-12.01	-
PB Ratio	0.36	0.39	-	-7.57	-
P/FCF Ratio	-0.50	-0.50	-164.64	-19.13	-
P/OCF Ratio	-0.50	-0.50	-164.64	-19.13	-
EV/EBITDA Ratio	-0.01	-0.01	-18.08	-14.61	-0.30
EV/EBIT Ratio	-0.01	-0.01	-18.07	-14.59	-0.30
EV/FCF Ratio	-0.14	-0.14	-164.64	-20.87	-0.71
Debt / Equity Ratio	0.00	0.00	-	-0.71	-0.43
Debt / EBITDA Ratio	0.00	0.00	-	-1.26	-0.31
Debt / FCF Ratio	0.00	0.00	-	-1.80	-0.75
Quick Ratio	0.31	0.31	-	0.02	0.02
Current Ratio	0.33	0.33	-	0.06	0.05
Interest Coverage	-	-	-31.86	-8.84	-23.56
Return on Equity (ROE)	-287.30%	-287.30%	-	74.40%	-
Return on Assets (ROA)	-210.50%	-210.50%	-	-892.40%	-
Return on Capital (ROIC)	-972.23%	-972.23%	-	209.36%	233.31%
Earnings Yield	-2644.46%	-2451.88%	-9.78%	-8.32%	-
FCF Yield	-217.06%	-201.25%	-0.61%	-5.23%	-
Buyback Yield / Dilution	-212.02%	95.97%	-3403.93%	-2.24%	-
Total Shareholder Return	-212.02%	95.97%	-3403.93%	-2.24%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).